Clinical Trial Update: DWP450 for Treating Moderate to Severe Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 trial update for DWP450 in treating moderate to severe glabellar lines has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Glabellar Lines

Drugs mentioned

• DWP450

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Moderate to Severe Glabellar Lines | Phase 3 | Status: COMPLETED